Evidence map›Paper›PMID 32521823›Full record

ArticleMicroorganisms2020

Shorter Antibacterial Peptide Having High Selectivity for

Adriana Barreto-Santamaría, Zuly Jenny Rivera, Javier Eduardo García, Hernando Curtidor, Manuel Elkin Patarroyo, Manuel Alfonso Patarroyo, Gabriela Arévalo-Pinzón

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Adriana Barreto-SantamaríaReceptor-Ligand Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Carrera 50#26-20, Bogotá 111321, Colombia.ORCID 0000-0003-3485-6934
Zuly Jenny RiveraChemistry Department, Sciences Faculty, Universidad Nacional de Colombia, Carrera 45#26-85, Bogotá 111321, Colombia.ORCID 0000-0001-6915-8488
Javier Eduardo GarcíaPharmacy Department, Sciences Faculty, Universidad Nacional de Colombia, Carrera 45#26-85, Bogotá 111321, Colombia.ORCID 0000-0001-6882-4397
Hernando CurtidorVicerrectoría de Investigación, Universidad ECCI, Carrera 19#49-20, Bogotá 111311, Colombia.ORCID 0000-0002-6556-7812
Manuel Elkin PatarroyoReceptor-Ligand Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Carrera 50#26-20, Bogotá 111321, Colombia.
Manuel Alfonso PatarroyoSchool of Medicine and Health Sciences, Universidad del Rosario, Carrera 24#63C-69, Bogotá 112111, Colombia.ORCID 0000-0002-4751-2500
Gabriela Arévalo-PinzónReceptor-Ligand Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Carrera 50#26-20, Bogotá 111321, Colombia.ORCID 0000-0002-5331-5693
Universidad Nacional de Colombia · COEscuela Colombiana de Carreras Industriales · COFundación Instituto de Inmunología de Colombia · COUniversity of Applied and Environmental Sciences · CO

Funding

Universidad Nacional de Colombia Grant 41569
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) have been recognised as a significant therapeutic option for mitigating resistant microbial infections. It has been found recently that

Indexed as

antimicrobial peptideminimum bactericidal concentration (MBC)minimum haemolytic concentration (MHC)minimum inhibitory concentration (MIC)therapeutic index (TI)

Identifiers

PMID32521823
PMCPMC7356157
OpenAlexW3033956935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.